SATT[1] Conectus and Find Therapeutics Sign Licensing Agreement to Develop a Promising New Therapy for Multiple Sclerosis and other demyelinating diseases

/CNW/ - Find Therapeutics Inc. (Montreal, Quebec) and SATT Conectus (Strasbourg, France) have signed an exclusive worldwide license to develop a promising...

Related Keywords

Canada ,Montreal ,Quebec ,Strasbourg ,Alsace ,France ,United States ,America ,Peptimimesis Pharma ,Gino Calabretta ,Dominique Bagnard ,Sclerosis Society Of Canada ,Transfert De Technologies Tech Transfer Acceleration Company ,University Of Strasbourg ,Therapeutics Inc ,Laboratory Of Myelin Biopathology ,Life Sciences ,Multiple Sclerosis ,Optic Neuritis ,North America ,Multiple Sclerosis Society ,Find Therapeutics ,Myelin Biopathology ,Therapeutic Strategies ,Mare Bioinnovations ,Domain Therapeutics ,Tech Transfer Acceleration Company ,Team Director ,Senior Manager ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Licensing ,New Products Amp Services ,